biostartr – the world’s first Synthetic Biology accelerator

  • Jun 30 2015 · is devoted to funding and building startups dedicated toward solving humanity’s most pressing problems with Life itself.
Did you know? IndieBio is short for Independent Biology, a new way for scientists, entrepreneurs, and tinkerers to shape their own destiny and make something that matters. provides seed funding and intensive mentorship to drive this transition in only three months, then launch our graduate companies into the world of biotechnology to make their fortune.


The world´s most scalable DNA synthesis platform

  • Jun 30 2015 · 

Twist Bioscience´s expertise is synthetic DNA which can be used in the following fields:

  • Biodetection
  • Functional Genomics
  • Genome Engineering
  • Drugs & Biodefense
  • Data Storage

Synthetic DNA for Health & Sustainability!
Read more!


May we introduce…Domain Associates!

  • Jun 26 2015 · 

Founded in 1985, Domain was one of the first venture capital firms to exclusively invest in the life sciences sector.

Domain has been involved in the formation of more than 250 companies.
More than $2.7 billion capital raised.

Investment Strategy
Domain’s primary investment areas are pharmaceuticals, diagnostics, and medical devices.  We also evaluate and opportunistically invest in evolving sectors of the life sciences industry, such as healthcare IT, and technologies addressing specific healthcare issues, such as healthcare economics.


A whole new age in Beekeeping!

  • Jun 26 2015 · 

Saving honeybees through technology!

The Smart Beehive Management System™ combines a set of technologies to address the increasingly worrying Colony Collapse Disorder.
Bee Smart Technologies’ solution, incorporates innovative technology and sustainable design in providing beekeepers with the power of saving honeybees and a tool that will directly influence, measure and enhance the life of colonies, improve yields, boost revenues and decrease costs.


Warwick Ventures Ltd

  • Jun 25 2015 · 

From Innovation to Impact!
Warwick Ventures commercialises innovations produced from world-leading research at the University of Warwick.
They offer advice and services to the University’s innovators. Their role is to support them throughout the process of generating impact and a commercial return from their research, whilst they maintain their academic focus.


Today´s biotech highlight

  • Jun 25 2015 · 

Combating antibiotic resistant bacteria using nature’s antidote!

Novolytics is developing treatments to combat infectious disease caused by antibiotic-resistant bacteria through the therapeutic use of bacteriophages.
Antibiotic resistant bacteria, such as MRSA and pseudomonas, are one of the most important threats to public health worldwide.
The solution: Phage Therapy!


UpStart Ventures

  • Jun 24 2015 · 

Entrepreneur LED VENTURE FUNDING for breakthrough life sciences startups with compelling investment potential!

UpStart Ventures start-ups and invests primarily in early-stage healthcare companies with disruptive market-shifting technologies. The investment strategy represents a unique combination of idea generation, science discovery, seed stage investing, venture judgment and company management.



Weekly BIOStartr Newsletter

  • Jun 24 2015 · 

Keep up with BIOStartr and the biotech and startup scene and sign up to our weekly newsletter!

Take a look at this week’s BIOStartr newsletter here and subscribe now to get your weekly update

In this Issue

  • The stats speak for themselves – statistics tell us that the risk of failure for a tech startup is way higher than biotech
  • New biotechs on BIOStartr –  BIOStartr welcomes Magnepath and S-Biomedic, two promising biotechs
  • A Dutch entrepreneur curing his ALS disease became BIO’s Superhero – Read the story about this year’s winner of the BIO Philadelphia „Everyday Superhero“ Award
  • Weekly biotech news –  BIOStartr provides you with the most important headlines regarding biotech and startups of this week

Biofabrication – impressions from the DLDSummer conference

  • Jun 24 2015 · 

Biofabrication – growing material using microorganisms – more precisely bacteria and yeast.

Who does exactly know what Biofabrication is? It´s originally a biomedical definition. However, now it is also used to describe processes where biological organisms are harnessed for the manufacture of material whose normal production harms nature.
At the DLDSummer conference 2015 in Munich three pioneers in the field of Biofabrication presented their innovative approaches to save animals and to protect nature.

Would you try a meat-free Hamburger consisting of muscle fibres? You should give it a try as it tastes neutral and is quite healthy in comparison to its meaty colleagues. The secret behind that meat-free Hamburger, which has been presented in 2013 the first time, is nothing more than a couple of stem cells derived from mammalian muscle tissue. These cells were triggered to proliferate into muscle tissue Peter Verstrate from Cultured Beef explains. The whole process takes about 3-4 weeks and is an innovative alternative to produce meat without having to kill animals.
A similar idea is persued by the company Modern Meadow which aims at developing cultured products of the highest quality, as Modern Meadow Creative Director Suzanne Lee points out. Modern Meadow is focused on exploring new ways to create sustainable animal materials like leather for example. The process of creating leather by making use of bacteria is similar to the creation of meat. Here also stems cells play the key role with the only difference that they are derived from skin tissue instead of muscle tissue. So, perhaps in the future one could wear leather bags or shoes without having a bad conscience about the animal’s fate. Sounds great, right?

Growing meat and leather sounds reasonable to some extent, but growing bricks? This is possible, too!
The company bioMASON has developed a technology using microorganisms to grow „biocement“ based construction materials. The biocement can be used as a green alternative, as the fuels used for the conventional brick production are a major cause for environmental pollution. Therefore, bioMASON enables enormous savings in energy costs and a reduction of carbon emissions. But how does this technology work? Ginger Krieg Dosier – CEO of bioMASON – explains that the main ingredients are only the following: bacteria + sand + aqueous solution. To sum it up: It is an ingenious fermentation process!

Learn more about these highly inventive biofabrication technologies:

Shared Form